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A case of myoﬁbroblastic sarcoma in the left hind limb is reported in a 4-year-old male,
mixed-breed horse. This report includes the clinical signs, macroscopic and microscopic
lesions, and the immunohistochemical ﬁndings related to this neoplasm.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Myoﬁbroblastic sarcoma, also known as myoﬁbrosar-
coma, is a rare malignant mesenchymal tumor composed
predominantly of differentiated myoﬁbroblasts. In humans,
the myoﬁbroblastic sarcoma occurs in both children and
adults alike and frequently affects the deep soft tissues of
the oral cavity, limbs, trunk, or abdominal and pelvic
cavities [1,2].
In animals, themyoﬁbroblastic sarcoma is rare; however,
it has been described as vaccine-associated sarcoma in cats
[3]. In equines, there are two reports of myoﬁbroblastic
sarcoma: one regarding sarcoma at the site of equine
inﬂuenzavaccination [4] and the other regarding sarcomaofVM, PhD, Departa-
de Veterinária da
nte Antônio Carlos,
, Brazil.
carino).
evier OA license.abdominal origin [5]. On the basis of histological features,
myoﬁbroblastic sarcomas are classiﬁed into three cate-
gories: low-grade (grade I), intermediate-grade (grade II),
and high-grade anaplasia (pleomorphic myoﬁbrosarcoma)
[6]. Myoﬁbroblastic sarcoma typically presents a low
frequency of metastasis, but local recurrence is frequent [7].
The differential diagnosis includes benign myoﬁbroblastic
lesions, especially nodular fasciitis and ﬁbromatosis, and
other types of low-grade spindle-cell sarcoma, such as
ﬁbrosarcoma and leiomyosarcoma [6]. A deﬁnitive diag-
nosis is based on a clinical evaluation and histopathological
and immunohistochemical results.
The present report describes the clinical, pathological,
and immunohistochemical ﬁndings related to myoﬁbro-
blastic sarcoma in a horse.
2. Case Report
A 4-year-old male, mixed-breed horse was admitted to
the Veterinary Teaching Hospital of the Universidade
Fig. 1. Myoﬁbroblastic sarcoma in the limb of a horse before the ﬁrst excision (A, B). (A) Large swelling of 25  63 cm2 in the subcutaneous tissue of the cranial
aspect of the left metatarsal. (B) Lateral radiograph of the cranial aspect of the left metatarsal showing a radio-opaque, circumscribed mass and the periosteal
reaction (arrow); recurrent myoﬁbroblastic sarcoma in the limb of a horse (C, D). (C) Recurrent tumor mass with an extension of 40  30  15 cm3 in the
subcutaneous tissue of the cranial aspect of the left metatarsal. (D) Gross appearance of the neoplastic mass showing its smooth surface and white yellowish
color.
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mately 25  63 cm2, located in the subcutaneous tissue of
the cranial aspect of the left metatarsal (Fig.1A). The animal
was found to be normal on clinical examination. The
hematology was unremarkable. Radiographic examination
revealed a radio-opaque mass that extended up to
approximately 25  63 cm2 and a metatarsal periosteal
reaction (Fig. 1B). The mass was removed by surgery and
sent for histopathological diagnosis.
Macroscopically, the mass was partially delimited,
white yellowish, and ﬁrm (Fig. 1A). Tissue samples of the
tumor mass were ﬁxed in 10% neutral buffered formalin,
embedded in parafﬁn, cut at 5 mm, and stained with
hematoxylin and eosin.
Histologically, neoplastic proliferation was observed to
be unencapsulated and inﬁltrative of the mesenchymal
cells. The cells were intensely pleomorphic with oval to
elongated nuclei with loose chromatin and prominent
nucleoli. The cytoplasm was sometimes eosinophilic and
indistinct and sometimes vacuolated (Fig. 2A). Areas of
myxomatous appearance were also observed. The mitoticindex was low with some atypical mitotic ﬁgures. Areas of
multifocal and intense neutrophilic inﬂammation associ-
ated with the ulceration of epithelium were observed.
One year after the surgery, there was local recurrence of
the neoplasia with an extension of 40 30  15 cm3 in size
(Fig.1C). Radiographic examination revealeda radio-opaque
mass inﬁltrative and associated with the metatarsal peri-
osteal reaction. The animal presented intense weight loss,
anemia, and locomotion and respiratory difﬁculty. Owing to
the unfavorable prognosis, the animal was euthanized.
Necropsy revealed that the neoplasia was poorly
demarcated, inﬁltrative, and associated with metatarsal
periosteal irregularity. The mass was white yellowish and
partially ﬁrm, with a discreet amount of serous liquid that
ﬂowed to the cut (Fig. 1D). Anemia, hydropericardium, and
pneumonia-affected areas were observed. The other organs
of the thoracic and abdominal cavity were not involved.
Tissue samples of the tumor mass, regional lymph nodes,
lungs, metatarsal bone, and organs of the abdominal and
thoracic cavities were collected for histological analysis.
Tissue sampleswereﬁxed in10%neutralphosphate-buffered
Fig. 2. Recurrent myoﬁbroblastic sarcoma in the limb of a horse.
(A) Neoplastic cells and ovoid to spindle-shaped cells organized in a solid
pattern (hematoxylin and eosin). Immunohistochemical expression of
(B) vimentin and (C) alpha-smooth muscle actin in the cytoplasm of the
neoplastic cells. Streptavidin-biotin-peroxidase method, Harris hematoxylin
counterstain. Scale bar ¼ 3.18 mm.
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hematoxylin and eosin.
To establish a ﬁnal diagnosis of the neoplasm, the
following antibodies were applied in appropriate dilutions:
antivimentin (clone V9), antiealpha-smooth muscle actin
(clone HHF 35), antidesmin (clone D33), anti-S100 protein
(code Z0311). The streptavidin-biotin-peroxidase complex
(Dako, Carpinteria, CA) and diaminobenzidine (Sigma
Chemical Co., St. Louis, MO) were used as the detection
system. The sections were counterstained with Harris
hematoxylin. Positive and negative controls were used toensure the accuracy of the results. The positive control was
human tissue positive for the antibodies used. The negative
control was tumoral tissue from the horse that had been
incubated with immunoglobulin G in substitution to
primary antibodies.
Microscopically, the recurrent tumor mass showed the
same histological appearance observed during the ﬁrst
excision.
Immunohistochemically, vimentin and alpha-smooth
muscle actin were strongly and diffusely positive in the
cytoplasm of the neoplastic cells (Fig. 2B, C); however, the
tumor cells were negative for desmin and S-100 protein.
Based on the pathologic and immunohistochemical
ﬁndings, the diagnosis of myoﬁbroblastic sarcoma was
conﬁrmed.
Myoﬁbroblasts are modiﬁed ﬁbroblasts, which occur in
stroma in some normal tissue, in inﬂammatory and repar-
ative granulation tissue, and as principal cells in some
reactive and neoplastic soft-tissue lesions [6]. The myoﬁ-
broblasts are probably derived from local ﬁbroblasts [8] that
acquire cytoplasmic actin-containing microﬁlaments in
response to mechanical stress [9]. Studies have shown that
the presence of myogenic differentiation in soft-tissue
pleomorphic sarcomas is associated with a worse prog-
nosis [10]. The etiology of myoﬁbroblastic sarcoma is
unknown. Some have postulated a postinﬂammatory or
posttraumatic process, but no identiﬁable precipitating
factor (infection, trauma, previous surgery) is consistently
noted [11], as was the case in the present report.
Myoﬁbroblastic sarcoma can be classiﬁed as low grade
(grade I) or intermediate grade (grade II), depending on the
presence of necrosis (up to 15% in grade II) and mitotic
activity. Low-grade myoﬁbroblastic sarcomas display
variable mitotic activity, but abnormal mitotic ﬁgures are
typically absent, and necrosis is rare [6]. Low-grade myo-
ﬁbroblastic sarcomas are associated with a more favorable
prognosis than intermediate-grade tumors. Myoﬁbro-
blastic sarcoma with high-grade anaplasia has a worse
prognosis, is characterized by myoﬁbroblastic differentia-
tion, and is usually only detected by electron microscopy
[6,12]. With respect to histological characteristics, the
myoﬁbroblastic sarcoma of the present report was classi-
ﬁed as intermediate grade (grade II). The metatarsal
periosteal reaction observed in radiographs and by
macroscopic analysis was characterized by benign bone
neoformation. Myoﬁbroblastic sarcoma cells had not inﬁl-
trated the bone tissue. This periosteal reaction was likely
because of the liberation of cytokines and growth factors
liberated by the neoplastic cells [13].
The criteria used to diagnose this neoplasm in domestic
animals are similar to those used in human cases and
include positive expression for vimentin and alpha-smooth
muscle actin and a lack of S-100 and desmin expression.
This immunohistochemical patternwas found in the tumor
investigated in this study.
The differential diagnosis includes benign myoﬁbro-
blastic lesions, especially nodular fasciitis and ﬁbromatosis,
and other types of low-grade spindle-cell sarcoma, such
as ﬁbrosarcoma and leiomyosarcoma. Nodular fasciitis
displays variable cellularity and myxoid microcysts con-
taining lymphocytes and erythrocytes and does not inﬁl-
trate into skeletal muscle or bone. Unlike myoﬁbroblastic
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necrosis [6]. Fibromatosis refers to a group of benign soft-
tissue tumors lacking cytologic and clinically malignant
features, a histology consistent with the proliferation of
well-differentiated ﬁbroblasts. Fibromatosis is also nega-
tive for alpha-smooth muscle actin [12].
Fibrosarcoma was excluded because the neoplastic cells
were positive for alpha-smooth muscle actin, and leiomyo-
sarcomawas eliminated because the cells were negative for
desmin. Histologically, leiomyosarcoma frequently presents
binucleate, multinucleate, and bizarre cell characteristics,
which were not observed in the present tumor [14].
Therefore, the positive expression of vimentin and
alpha-smooth muscle actin and the negative expression of
desmin and S-100 protein support the diagnosis of myoﬁ-
broblastic sarcoma in this case.Acknowledgments
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